Cancer remains the second leading cause of death in the United States. It is estimated that over 560,000 individuals in the US will die from cancer during 2004 and 1,368,030 new cases will be diagnosed. Historically, natural products or compounds modeled on them, have found significant utility in the treatment of cancer. A number of marine-derived compounds are currently under clinical investigation for the treatment of cancer, including discodermolide, a compound discovered at HBOI from a deep-water sponge, and brought to the clinic by Novartis. Advances in our understanding of neoplastic progression have provided new targets for intervention in cancer and the discovery of compounds which selectively act on these targets has begun to provide novel therapies with limited, if any, side effects. In this proposal we will continue to substantiate our hypothesis that marine natural products (MNPs) can be discovered which interact at these defined molecular targets and that these compounds, or compounds modeled upon them, will be useful in the treatment of cancer. The project will be carried out in collaboration with the Novartis Institute of Biomedical Research, Inc. (NIBRI), the Crews MNP group at UC Santa Cruz (UCSC), the Gerwick group at Oregon State University (OSU) and the Fenical group at Scripps Institute of Oceanography (SIO). HBOI brings to the NCDDG a complementary set of organisms and expertise.
The Specific Aims for this Project are as follows: 1. To create a diverse and complementary library of highly enriched fractions/pure materials (""""""""a peak library"""""""") derived from Atlantic and Caribbean marine organisms. 2. To submit the materials to NIBRI for assay in their panel of epigenetic and molecular screens and use these assays to follow purification when necessary. 3. To utilize state-of-the-art MS and NMR techniques for rapid and accurate dereplication and structure elucidation of candidate compounds. 4. To provide sufficient compound to the NIBRI to allow for secondary biological testing and follow up.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19CA052955-20
Application #
7842697
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
20
Fiscal Year
2009
Total Cost
$292,902
Indirect Cost
Name
University of California Santa Cruz
Department
Type
DUNS #
125084723
City
Santa Cruz
State
CA
Country
United States
Zip Code
95064
Sabry, Omar M; Goeger, Douglas E; Gerwick, William H (2017) Biologically active new metabolites from a Florida collection of Moorea producens. Nat Prod Res 31:555-561
Sabry, Omar M M; Goeger, Douglas E; Valeriote, Frederick A et al. (2017) Cytotoxic halogenated monoterpenes from Plocamium cartilagineum. Nat Prod Res 31:261-267
Sabry, Omar M M; Goeger, Douglas E; Gerwick, William H (2017) Bioactive new metabolites from the green alga Udotea orientalis growing on the Gorgonian coral Pseudopterogorgia rigida. Nat Prod Res 31:1245-1250
Guzmán, Esther A; Maers, Kelly; Roberts, Jill et al. (2015) The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells. Invest New Drugs 33:86-94
Tan, Lik Tong; Okino, Tatsufumi; Gerwick, William H (2013) Bouillonamide: a mixed polyketide-peptide cytotoxin from the marine cyanobacterium Moorea bouillonii. Mar Drugs 11:3015-24
Jiang, Hai-Long; Luo, Xiao-Hong; Wang, Xiao-Zheng et al. (2012) New isocoumarins and alkaloid from Chinese insect medicine, Eupolyphaga sinensis Walker. Fitoterapia 83:1275-80
Wu, Q X; Jin, X J; Draskovic, M et al. (2012) Unraveling the Numerous Biosynthetic Products of the Marine Sediment-Derived Fungus, Aspergillus insulicola. Phytochem Lett 5:114-117
Malloy, Karla L; Choi, Hyukjae; Fiorilla, Catherine et al. (2012) Hoiamide D, a marine cyanobacteria-derived inhibitor of p53/MDM2 interaction. Bioorg Med Chem Lett 22:683-8
Luo, Xiao-Hong; Wang, Xiao-Zheng; Jiang, Hai-Long et al. (2012) The biosynthetic products of Chinese insect medicine, Aspongopus chinensis. Fitoterapia 83:754-8
Valeriote, Frederick A; Tenney, Karen; Media, Joseph et al. (2012) Discovery and development of anticancer agents from marine sponges: perspectives based on a chemistry-experimental therapeutics collaborative program. J Exp Ther Oncol 10:119-34

Showing the most recent 10 out of 47 publications